Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan



Survival: 11.1 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: Japan
   
City/State/Province: Matsuyama, Ehime
   
Hospital: National Hospital Organization Shikoku Cancer Center
   
Journal: Link
   
Date: 10/2011

Description:
Patients:
This phase II study involved 80 women with pretreated metastatic breast cancer. The median age was 54.0 years.

Treatment:
Patients were treated with the chemotherapy agent eribulin.

Toxicities:
There was one treatment-related death due to disease progression and infection. Grade 3/4 neutropenia (95.1% of patients) and leukopenia (74.1%) were also reported. In addition, 58% of patients experienced alopecia and 39.5% had stomatitis (inflamed lining of the intestinal tract).

Results:
The reported median overall survival was 11.1 months.

Support:
This study was supported by the pharmaceutical company Eisai, Inc.

Correspondence: Dr. K. Aogi; email: kaogi@shikoku-cc.go.jp

E-mail to a Friend Email Physician More Information